MedPath

Changes in cerebral activity and connectivity induced by transcranial stimulation of the dorsolateral prefrontal cortex in healthy humans

Completed
Conditions
transcraniale prefrontale stimulatie met gezonde proefpersonen
This study is not aimed at a certain disorder. It is a study with healthy subjects.
Registration Number
NL-OMON42853
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

[1] Healthy males and females,
[2] 18 years old or older,
[3] Normal (or corrected to normal) vision,
[4] Right-handed

Exclusion Criteria

[1] (History of) significant medical, psychiatric or neurological conditions,
[2] Metal implants in the body (e.g., pacemaker, heart valves, vascular clips, eye-implants, copper containing intra-uterine devices, non-removable piercing, cerebral implants),
[3] Any risk of having metal particles in the eyes,
[4] Tattoos containing iron oxide,
[5] (Suspected) pregnancy, or breast feeding
[6] Claustrophobia,
[7] Drug or alcohol abuse,
[8] Use of psycho-active medication,
[9] Refusal to be informed about structural brain abnormalities,
[10] Epilepsy or family history of epilepsy,
[11] Use of medication associated with increased epileptic seizure risk,
[12] Neurological problems in the past or present (including brain surgery, infarction, stroke, and the intake of medication that could increase the risk of stroke),
[13] Severe scalp skin lesions.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameters are the changes in blood-oxygenation-level dependent<br /><br>(BOLD) signal induced by transcranial brain stimulation. We will measure the<br /><br>BOLD signal at rest and during the performance on two different tasks tapping<br /><br>executive functions using fMRI. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>In addition, we will measure cerebral blood flow (CBF) using the arterial spin<br /><br>labeling technique, and we will record MR spectroscopy data from the dorsal<br /><br>striatum. </p><br>
© Copyright 2025. All Rights Reserved by MedPath